BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 36347723)

  • 1. Plasma exosomes generated by ischaemic preconditioning are cardioprotective in a rat heart failure model.
    Luo Z; Hu X; Wu C; Chan J; Liu Z; Guo C; Zhu R; Zhang L; Zhang Y; Jin S; He S
    Br J Anaesth; 2023 Jan; 130(1):29-38. PubMed ID: 36347723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardioprotection by remote ischemic preconditioning of the rat heart is mediated by extracellular vesicles.
    Giricz Z; Varga ZV; Baranyai T; Sipos P; Pálóczi K; Kittel Á; Buzás EI; Ferdinandy P
    J Mol Cell Cardiol; 2014 Mar; 68():75-8. PubMed ID: 24440457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ischaemic preconditioning-induced serum exosomes protect against myocardial ischaemia/reperfusion injury in rats by activating the PI3K/AKT signalling pathway.
    Zhang J; Zhang X
    Cell Biochem Funct; 2021 Mar; 39(2):287-295. PubMed ID: 32767595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The significance of the washout period in preconditioning.
    Salie R; Lochner A; Loubser DJ
    Cardiovasc Ther; 2017 Jun; 35(3):. PubMed ID: 28118517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of myocardial apoptosis by ischaemic and beta-adrenergic preconditioning is dependent on p38 MAPK.
    Moolman JA; Hartley S; Van Wyk J; Marais E; Lochner A
    Cardiovasc Drugs Ther; 2006 Feb; 20(1):13-25. PubMed ID: 16552474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin II-preconditioning is associated with increased PKCε/PKCδ ratio and prosurvival kinases in mitochondria.
    Nuñez RE; Javadov S; Escobales N
    Clin Exp Pharmacol Physiol; 2017 Dec; 44(12):1201-1212. PubMed ID: 28707739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardioprotection by the transfer of coronary effluent from ischaemic preconditioned rat hearts: identification of cardioprotective humoral factors.
    Maciel L; de Oliveira DF; Verissimo da Costa GC; Bisch PM; Nascimento JHM
    Basic Res Cardiol; 2017 Sep; 112(5):52. PubMed ID: 28695353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morphine preconditioning confers cardioprotection in doxorubicin-induced failing rat hearts via ERK/GSK-3β pathway independent of PI3K/Akt.
    He SF; Jin SY; Wu H; Wang B; Wu YX; Zhang SJ; Irwin MG; Wong TM; Zhang Y
    Toxicol Appl Pharmacol; 2015 Nov; 288(3):349-58. PubMed ID: 26296503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenosine-A1 receptors activation restores the suppressed cardioprotective effects of ischemic preconditioning in hyperhomocysteinemic rat hearts.
    Balakumar P; Singh H; Reddy K; Anand-Srivastava MB
    J Cardiovasc Pharmacol; 2009 Sep; 54(3):204-12. PubMed ID: 19568176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrophage migration inhibitory factor plays an essential role in ischemic preconditioning-mediated cardioprotection.
    Ruze A; Chen BD; Liu F; Chen XC; Gai MT; Li XM; Ma YT; Du XJ; Yang YN; Gao XM
    Clin Sci (Lond); 2019 Mar; 133(5):665-680. PubMed ID: 30804219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effluent from ischemic preconditioned hearts confers cardioprotection independent of the number of preconditioning cycles.
    Feige K; Raupach A; Torregroza C; Muehlenbernd J; Stroethoff M; Bunte S; Hollmann MW; Huhn R
    PLoS One; 2020; 15(12):e0243220. PubMed ID: 33270768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of the malate-aspartate shuttle by pre-ischaemic aminooxyacetate loading of the heart induces cardioprotection.
    Støttrup NB; Løfgren B; Birkler RD; Nielsen JM; Wang L; Caldarone CA; Kristiansen SB; Contractor H; Johannsen M; Bøtker HE; Nielsen TT
    Cardiovasc Res; 2010 Nov; 88(2):257-66. PubMed ID: 20562422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of the miR-144/451 cluster impairs ischaemic preconditioning-mediated cardioprotection by targeting Rac-1.
    Wang X; Zhu H; Zhang X; Liu Y; Chen J; Medvedovic M; Li H; Weiss MJ; Ren X; Fan GC
    Cardiovasc Res; 2012 May; 94(2):379-90. PubMed ID: 22354898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myocardial Infarct Size Reduction Provided by Local and Remote Ischaemic Preconditioning: References Values from the Hatter Cardiovascular Institute.
    Rossello X; He Z; Yellon DM
    Cardiovasc Drugs Ther; 2018 Apr; 32(2):127-133. PubMed ID: 29656359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection of the ischaemic heart: investigations into the phenomenon of ischaemic preconditioning.
    Lochner A; Marais E; Genade S; Huisamen B; du Toit EF; Moolman JA
    Cardiovasc J Afr; 2009; 20(1):43-51. PubMed ID: 19287816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Right ventricular hypertrophy and failure abolish cardioprotection by ischaemic pre-conditioning.
    Andersen A; Povlsen JA; Bøtker HE; Nielsen-Kudsk JE
    Eur J Heart Fail; 2013 Nov; 15(11):1208-14. PubMed ID: 23818649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Possible role of JAK-2 in attenuated cardioprotective effect of ischemic preconditioning in hyperhomocysteinemic rat hearts.
    Singh G; Rohilla A; Singh M; Balakumar P
    Yakugaku Zasshi; 2009 May; 129(5):523-35. PubMed ID: 19420883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A kallidin-like peptide is a protective cardiac kinin, released by ischaemic preconditioning of rat heart.
    Liu X; Lukasova M; Zubakova R; Lewicka S; Hilgenfeldt U
    Br J Pharmacol; 2005 Dec; 146(7):952-7. PubMed ID: 16231012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of hyperglycemia on myocardial ischemia-reperfusion susceptibility and ischemic preconditioning in hearts from rats with type 2 diabetes.
    Kristiansen SB; Pælestik KB; Johnsen J; Jespersen NR; Pryds K; Hjortbak MV; Jensen RV; Bøtker HE
    Cardiovasc Diabetol; 2019 May; 18(1):66. PubMed ID: 31151453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytochrome P450 2J3/epoxyeicosatrienoic acids mediate the cardioprotection induced by ischaemic post-conditioning, but not preconditioning, in the rat.
    Yu GG; Zeng XJ; Wang HX; Lu LQ; Zheng SP; Ma LQ; Chang J; Wang J; Zhang DM; Du FH; Zhang LK
    Clin Exp Pharmacol Physiol; 2011 Jan; 38(1):63-70. PubMed ID: 21105892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.